{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:42:22Z","timestamp":1793814142887,"version":"4.6.1"},"reference-count":40,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"High Level Chinese Medical Hospital Promotion Project - Special Project on Formulation R&D and New Drug Translation for Medical Institutions","award":["HLCMHPP2023037"],"award-info":[{"award-number":["HLCMHPP2023037"]}]},{"name":"High Level Chinese Medical Hospital Promotion Project - Special Project on Formulation R&D and New Drug Translation for Medical Institutions","award":["HLCMHPP2023037"],"award-info":[{"award-number":["HLCMHPP2023037"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474354"],"award-info":[{"award-number":["82474354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2024.2424611","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:24:15Z","timestamp":1736137455000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["PD-1\/PD-L1 inhibitors related adverse events: A bibliometric analysis from 2014 to 2024"],"prefix":"10.1080","volume":"21","author":[{"given":"Qingya","family":"Song","sequence":"first","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliang","family":"Yu","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5589-1048","authenticated-orcid":false,"given":"Wenping","family":"Lu","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Zhuo","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heting","family":"Mei","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjia","family":"Cui","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongni","family":"Zhang","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0235-4"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.627612"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.5009"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.02.048"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.001"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.05.003"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv623"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.016"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.04.002"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0020"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1096806"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1242336"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-024-03100-4"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307513100"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joi.2017.08.007"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/2158244019829575"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.77.6385"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0218-0"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv383"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2925"},{"key":"e_1_3_7_26_1","first-page":"180","article-title":"Opdivo (nivolumab): second PD-1 inhibitor receives FDA approval for unresectable or metastatic melanoma","volume":"8","author":"Raedler LA","year":"2015","unstructured":"Raedler LA. Opdivo (nivolumab): second PD-1 inhibitor receives FDA approval for unresectable or metastatic melanoma. Am Health Drug Benefits. 2015;8(Spec Feature):180\u2013183.","journal-title":"Am Health Drug Benefits"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-11-1595"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.02229"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1199310"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(19)30167-6"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709937"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32222-6"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-17-0226"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-17-0386"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.5258"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(19)30084-0"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)02405-4"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.01891"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.3779\/j.issn.1009-3419.2023.101.17"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2424611","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2024.2424611","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2424611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:43:12Z","timestamp":1786034592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2024.2424611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2024.2424611"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2024.2424611","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2424611"}}